Abstract:This study provides a comprehensive analysis of liquid biopsies in patients with melanoma, an aggressive form of skin cancer. We profiled cfDNA using these various genetic and epigenetic approaches and we subsequently compared cfDNA to circulating tumor cells with the aim to increase the sensitivity of blood‐based tumor detection. Advances in therapeutic approaches for melanoma urge the need for biomarkers that can identify patients at risk for recurrence and to guide treatment. The potential use of liquid biopsies in identifying biomarkers is increasingly being recognized. Here, we present a head‐to‐head comparison of several techniques to analyze circulating tumor cells (CTCs) and cell‐free DNA (cfDNA) in 20 patients with metastatic melanoma. In this study, we investigated whether diagnostic leukapheresis (DLA) combined with multimarker flow cytometry (FCM) increased the detection of CTCs in blood compared to the CellSearch platform. Additionally, we characterized cfDNA at the level of somatic mutations, extent of aneuploidy and genome‐wide DNA methylation. Both CTCs and cfDNA measures were compared to tumor markers and extracranial tumor burden on radiological imaging. Compared to the CellSearch method applied on peripheral blood, DLA combined with FCM increased the proportion of patients with detectable CTCs from 35% to 70% (P = 0.06). However, the median percentage of cells that could be recovered by the DLA procedure was 29%. Alternatively, cfDNA mutation and methylation analysis detected tumor load in the majority of patients (90% and 93% of samples successfully analyzed, respectively). The aneuploidy score was positive in 35% of all patients. From all tumor measurements in blood, lactate dehydrogenase (LDH) levels were significantly correlated to variant allele frequency (P = 0.004). Furthermore, the presence of CTCs in DLA was associated with tumor burden (P

Label-free counting of circulating cells by in vivo photoacoustic flow cytometry

In vivo, label-free, and noninvasive detection of melanoma metastasis by photoacoustic flow cytometry

Noninvasive and Label-Free Detection of Circulating Melanoma Cells by in Vivo Photoacoustic Flow Cytometry

Label-free Counting of Circulating Melanoma Cells in Deep Vessels with Photoacoustic Flow Cytometry

Progress in Detection of CirculatingTumor Cell byin vivo Photoacoustic Flow Cytometry

In vivo photoacoustic flow cytometry‐based study of the effect of melanin content on melanoma metastasis

Photoacoustic Signal Classification for in Vivo Photoacoustic Flow Cytometry Based on Support Vector Machine

In Vivo Dynamic Monitoring of Circulating Melanoma Cells and the Inhibitory Effect of PD-L1 Inhibitor Based on PAFC Equipped with a Deep Learning Framework

In Vivo Cell Characteristic Extraction and Identification by Photoacoustic Flow Cytography.

Improving the Signal Analysis for in Vivo Photoacoustic Flow Cytometry

Application of Convolutional Neural Network in Signal Classification for in Vivo Photoacoustic Flow Cytometry

Real-time Detection of Circulating Apoptotic Cells by in Vivo Flow Cytometry

Monitoring circulating tumor cells in vivo by a confocal microscopy system

Quantitative Analysis on in Vivo Tumor‐microvascular Images from Optical‐resolution Photoacoustic Microscopy

Toward in Vivo Biopsy of Melanoma Based on Photoacoustic and Ultrasound Dual Imaging with an Integrated Detector.

In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen

Postoperative Evaluation of Tumours Based on Label-Free Acoustic Separation of Circulating Tumour Cells by Microstreaming.

In Vivo Flow Cytometry: A New Method for Monitoring Circulating Cancer Cells

Integrated photoacoustic and hyperspectral dual modality microscope for co-imaging of melanoma and cutaneous squamous cell carcinoma in vivo.

Comprehensive characterization of circulating tumor cells and cell‐free DNA in patients with metastatic melanoma

A Novel Approach to Harnessing Acoustic A-Lines to Detect Circulating Tumor Cells in Flowing Blood